Congress Asset Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,983
Closed -$824K 401
2026
Q1
$824K Buy
15,983
+2,916
+22% +$204K 0.01% 349
2025
Q4
$1.21M Sell
13,067
-434
-3% -$41.5K 0.01% 304
2025
Q3
$1M Sell
13,501
-359,846
-96% -$36.4M 0.01% 318
2025
Q2
$48.4M Buy
373,347
+65,792
+21% +$9.54M 0.33% 112
2025
Q1
$49M Buy
307,555
+299,949
+3,944% +$54.3M 0.37% 107
2024
Q4
$1.41M Buy
7,606
+2,077
+38% +$403K 0.01% 298
2024
Q3
$1.17M Buy
5,529
+1,292
+30% +$224K 0.01% 297
2024
Q2
$567K Sell
4,237
-11,736
-73% -$2.22M ﹤0.01% 319
2024
Q1
$3.43M Sell
15,973
-1,219
-7% -$239K 0.02% 250
2023
Q4
$3.5M Buy
+17,192
New +$2.79M 0.03% 260

Other funds holding INSP

Congress Asset Management's INSP Position: Q2 2026 in Review

Congress Asset Management sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 15,983 shares — an estimated $824K sold.

Congress Asset Management first reported a position in INSP in Q4 2023 and held it in 10 quarters. The position peaked at $49M in Q1 2025. 25 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Congress Asset Management reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
  • Congress Asset Management sold 15,983 Inspire Medical Systems shares in Q2 2026, an estimated $824K.
  • Congress Asset Management first reported a position in Inspire Medical Systems in Q4 2023 and held it in 10 quarters.
  • Congress Asset Management's Inspire Medical Systems position peaked at $49M in Q1 2025.
  • 25 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Congress Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.